NAUTILUS
LIVE

Serial Number

97473604

Owner

Nautilus Biotechnology, Inc.

Attorney

Carla B. Oakley

Filing Date

Jun 23, 2022

Add to watchlist:

No watchlists yet
View on USPTO

NAUTILUS Trademark

Serial Number: 97473604

NAUTILUS is a trademark filed by Nautilus Biotechnology, Inc. on June 23, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Nautilus Biotechnology, Inc. (2 trademarks)

2701 Eastlake Ave East, Suite 300
Seattle, WA 98102

Entity Type: 03

Trademark Details

Filing Date

June 23, 2022

Registration Date

Not Registered

Published for Opposition

June 13, 2023

Goods & Services

Medical testing for diagnostic or treatment purposes

Assays and reagents for use in biologic and medical research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagents and reagent kits comprised primarily of amino acids, naturally occurring or modified proteins, affinity reagents, enzymes, chemical or nano-particle labels, and chemical buffers, all for the purpose of preparing, detecting, sequencing, quantifying and analyzing proteins and other biological molecules, samples of biological molecules, proteins, proteomes, protein sequence variants and modifications, regulation, translation, and expression in the fields of scientific, diagnostic and clinical research; chemical standards solutions used in DNA, RNA and protein analysis, chemicals used in protein analysis systems; DNA labeling reagents; DNA hybridization buffers solutions

Scientific research; medical research; Protein screening for scientific research purposes; cloud hosting provider services for storing, analyzing and sharing biological information; providing an online network service that enables users to store, analyze and share data in the fields of life science; technical support services, namely, infrastructure management services for monitoring, administration and management of cloud computing IT and application systems in the fields of life science; design and development of laboratory apparatus and instruments and computer systems for use in analysis of biomolecules; installation and maintenance of computer software and databases used in the field of analysis of biomolecules; consultancy, information and advisory services in the field of analysis of biomolecules; product development, namely, developing equipment for use in preparing, detecting, sequencing, quantifying and analyzing proteins and other biological molecules, and automated laboratory equipment and systems, and computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data to the order and specification of others, all the foregoing in the fields of scientific and clinical research

Laboratory equipment, namely, a device for molecular analysis of proteins; laboratory instrument for protein analysis including chemical and biochemical reactions; medical laboratory research instrument for molecular analysis and sequencing including chemical and biochemical reactions; automated laboratory apparatus and computer systems for use in analysis of biomolecules; proteome quantifiers in the nature of proteome analyzers; automated laboratory apparatus and systems, namely, sample loaders and bar code readers; laboratory equipment, namely, an apparatus for screening samples, detecting the presence of analytes in samples, and identifying sample type, together with measuring patterns and laboratory equipment for making molecular arrays, and parts therefor

Reagents for medical use; clinical medical reagents; medical diagnostic reagents and assays for testing bodily fluids; diagnostic biomarker reagents for medical purposes; medical diagnostic reagents and assays for testing cells, bodily fluids and tissue for disease detection, monitoring and prognosis

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 8, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 8, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 8, 2026 REAP
SOU TEAS EXTENSION RECEIVED
Feb 6, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 23, 2025 EXRA
SOU EXTENSION 4 GRANTED
Jul 23, 2025 EX4G
SOU EXTENSION 4 FILED
Jul 22, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 22, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 3 GRANTED
Jan 18, 2025 EX3G
SOU EXTENSION 3 FILED
Jan 18, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 17, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 16, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jul 16, 2024 EX2G
SOU EXTENSION 2 FILED
Jul 16, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 16, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 31, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jan 29, 2024 EX1G
SOU EXTENSION 1 FILED
Jan 29, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 29, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 8, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 13, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jun 13, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 24, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 8, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 30, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 29, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 29, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 18, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 18, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 18, 2022 CNRT
ASSIGNED TO EXAMINER
Oct 12, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 13, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 12, 2022 NWOS
NEW APPLICATION ENTERED
Jun 27, 2022 NWAP